American Regent is
recalling Ketorolac Tromethamine Injections due to potentially fatal adverse reaction. Kertorolac Tromethamine Injections are most commonly used to treat moderate to severe pain in patients after surgury.
The potentially fatal injection is being recalled after the American Regent was made aware of adverse reactions to the drug which include blood clots and obstruction of blood vessels. Additional adverse reactions include
anaphylactic reactions and secondary complications due to injection site irritations.
The Ketorolac Tromethamine injection recall includes all lot numbers of the Ketorolac Tromethamine Injection, USP, 15 mg/mL, 1mL single dose vial, with the NDC number 0517-0601-25. The product was mainly distributed to hospitals, doctors and clinics but may have also been distributed to pharmacy's for patients.
If you have suffered severe adverse reactions to this injection you may want to consider contacting a
product liability lawyer to review your injury case after you seek the proper medical treatment. To contact a product liability lawyer in Staten Island New York call 800.976.4904 or fill out our
web form and we will get back to you regarding your drug injury case.
Category: Personal Injury
To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."